0001696916-19-000001.txt : 20190304 0001696916-19-000001.hdr.sgml : 20190304 20190304153022 ACCESSION NUMBER: 0001696916-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190304 DATE AS OF CHANGE: 20190304 EFFECTIVENESS DATE: 20190304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAVU Biotherapies, Inc. CENTRAL INDEX KEY: 0001696916 IRS NUMBER: 810844114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-334003 FILM NUMBER: 19653483 BUSINESS ADDRESS: STREET 1: 1 HERMANN MUSEUM CIRCLE DRIVE STREET 2: NO. 2096 CITY: HOUSTON STATE: TX ZIP: 77004 BUSINESS PHONE: 8598167399 MAIL ADDRESS: STREET 1: 5000 GULF FWY ERP BUILDING 5 RM 115 CITY: HOUSTON STATE: TX ZIP: 77023 D 1 primary_doc.xml X0708 D LIVE 0001696916 CAVU Biotherapies, Inc. 8285 El Rio Suite 110 HOUSTON TX TEXAS 77054 7133802758 DELAWARE None None Corporation true 2015 Colleen O'Connor 8285 El Rio Suite 110 HOUSTON TX TEXAS 77054 Executive Officer Director Biotechnology Decline to Disclose 06b false 2019-02-12 false true true Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon conversion false 0 1500000 50000 1450000 false 1 0 0 0 false CAVU Biotherapies, Inc. Colleen O'Connor Colleen O'Connor President 2019-02-28